Form 4 for RXST RxSight, Inc.
Accepted 2025-04-15 00:00:00 ET · period of report 2025-04-14 · accession 0000950170-25-054439 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-04-15 | 2025-04-14 | RXST | Thunen Shelley B | See remarks | M - OptEx | $4.34 | +7,792 | 38.4K | +25% | +$33.8K |
| DM | 2025-04-15 | 2025-04-14 | RXST | Thunen Shelley B | See remarks | M - OptEx | $0.00 | -7,792 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-04-14 | M | A | 7,792 | $4.34 | 38,354 | D | — | — | (F1) Includes 119 shares of Common Stock acquired October 31, 2024 under the Issuer's 2021 Employee Stock Purchase Plan. |
| 2 | Derivative | Stock Option (right to buy) | 2025-04-14 | M | D | 6,405 | $0.00 | 0 | D | $4.34 · 2020-10-27 to 2026-10-26 | 6,405 Common Stock | (F2) Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended. |
| 3 | Derivative | Stock Option (right to buy) | 2025-04-14 | M | D | 1,387 | $0.00 | 0 | D | $4.34 · 2021-02-24 to 2027-03-13 | 1,387 Common Stock | (F2) Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended. |